News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymotec Announces Pricing Of Secondary Offering


2/28/2014 9:46:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced the pricing of a registered secondary public offering. The size of the offering has been increased to 4,698,857 ordinary shares at a price of $28.00 per share. The underwriters have a 30-day option to purchase up to an additional 704,828 ordinary shares at the public offering price. All of the shares are being sold by the Company's shareholders. The Company will not receive any proceeds from the sale of these shares. The offering is expected to close on March 5, 2014, subject to customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Enzymotec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES